RVMD — Revolution Medicines Inc. price, chart and key statistics

Price data

Price

$190.95

Change YTD

+139.74%

Next earnings

Nov 4, 2026

Market cap

40.9B2020-03 1.3B2026-09 40.9B+3065.3% over the window

Enterprise value

37.1B

Shares outstanding

214.3M2019-12 3.3M2026-06 214.3M+6410.6% over the window

52W low

$42.18

52W high

$224.31

From 52W high

-14.87%

From 52W low

+352.70%

52W range

82%

Beta

1.39

Volume

Rel volume

3.18×

30D volume

1.9M

30D $ vol

385.2M

Fundamentals

EPS (ttm)

-$8.922020-12 -$2.012026-06 -$8.92+343.9% over the window

FCF (ttm)

-1.2B2018-12 -286K2026-06 -1.2B+430715.0% over the window

FCF/share

-$5.752019-12 -$15.862026-06 -$5.75-63.7% over the window

Book value/share

$12.162019-06 -$38.792026-06 $12.16-131.3% over the window

ROE

-67.85%2020-03 -14.8%2026-06 -67.8%+358.2% over the window

ROA

-40.90%2019-12 -21.6%2026-06 -40.9%+89.2% over the window

Current ratio

11.382019-12 3.112026-06 11.38+265.6% over the window

Growth (CAGR, ttm) · 10Y

Shares

+14.67%2025-06-30 → 2026-06-30186.9M → 214.3M (+14.7% total)+24.08%2023-03-31 → 2026-06-30106.3M → 214.3M (+101.6% total)+23.85%2021-06-30 → 2026-06-3073.6M → 214.3M (+191.3% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+21.87%2025-06-30 → 2026-06-30$9.98 → $12.16 (+21.9% total)+9.86%2023-03-31 → 2026-06-30$8.96 → $12.16 (+35.8% total)+5.49%2021-06-30 → 2026-06-30$9.31 → $12.16 (+30.6% total)n/a

Price

+322.69%2025-09-18 → 2026-09-18$45.22 → $190.95 (+322.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+83.42%2023-09-18 → 2026-09-18$30.93 → $190.95 (+517.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+43.62%2021-09-17 → 2026-09-18$31.23 → $190.95 (+511.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+322.69%2025-09-18 → 2026-09-18$45.22 → $190.95 (+322.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+83.42%2023-09-18 → 2026-09-18$30.93 → $190.95 (+517.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+43.62%2021-09-17 → 2026-09-18$31.23 → $190.95 (+511.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-21.4×2020-03 -22.662026-09 -23.15+2.1% over the window

Fwd P/E

-32.9×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

15.7×2020-03 3.362026-09 15.70+368.0% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-3.01%2019-12 -4.0%2026-06 -3.1%-24.0% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 214.3M ÷ 186.9M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-14.67%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-14.67%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($6.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-14.67%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-1.7B) ÷ today's market cap ($40.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-4.03%2019-12 0.0%2026-06 -4.1%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-1.7B + TTM dividends $0) ÷ today's market cap ($40.9B). Same caveat as the cash buyback yield.

-4.03%2019-12 0.0%2026-06 -4.1%

Vs own 10Y history

P/S

92nd

P/B

95th